ABT-199-mediated inhibition of Bcl-2 as a potential therapeutic strategy for nasopharyngeal carcinoma-Reference-Cited by-同舟云学术

ABT-199-mediated inhibition of Bcl-2 as a potential therapeutic strategy for nasopharyngeal carcinoma

Published:2018-09 Issue:3 Volume:503 Page:1214-1220
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Wang Yujie,Wang Yuyang,Fan Xiaoqin,Song Jian,Wu Hanwei,Han Jinghong,Lu Lu,Weng Xin,Nie Guohui

Funder

China Postdoctoral Foundation

Shenzhen Science and Technology Innovation Committee

Sanming Project of Medicine in Shenzhen

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference25 articles.

1. The enigmatic epidemiology of nasopharyngeal carcinoma;Chang;Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,2006

2. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure;Lee;Int. J. Radiat. Oncol. Biol. Phys.,1992

3. Treatment approaches to nasopharyngeal carcinoma: a review;Caponigro;Anti Canc. Drugs,2010

4. Novel therapy for nasopharyngeal carcinoma–where are we;Tsang;Oral Oncol.,2014

5. BCL-2 family proteins: critical checkpoints of apoptotic cell death;Danial;Clin. Canc. Res. :Off. J. Am. Assoc. Canc. Res.,2007

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overexpression of antiapoptotic gene products and resistance to trastuzumab treatment of breast cancer;Overcoming Cancers Resistant to HER-2 Antibodies;2024

2. Current Advances and Future Strategies for BCL-2 Inhibitors: Potent Weapons against Cancers;Cancers;2023-10-12

3. Dual targeting of BCL-2 and MCL-1 in the presence of BAX breaks venetoclax resistance in human small cell lung cancer;British Journal of Cancer;2023-03-14

4. Anticancer effects of putative and validated BH3-mimetic drugs in head and neck squamous cell carcinomas: An overview of current knowledge;Oral Oncology;2022-09

5. Dual inhibition of anti-apoptotic proteins BCL-XL and MCL-1 enhances cytotoxicity of Nasopharyngeal carcinoma cells;Discover Oncology;2022-02-03